ritanserin (BioDeep_00000182960)

   

human metabolite blood metabolite


代谢物信息卡片


6-(2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl)-7-methyl-5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one

化学式: C27H25F2N3OS (477.1686)
中文名称: 利坦色林
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CC1=C(C(=O)N2C=CSC2=N1)CCN3CCC(=C(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F)CC3
InChI: InChI=1S/C27H25F2N3OS/c1-18-24(26(33)32-16-17-34-27(32)30-18)12-15-31-13-10-21(11-14-31)25(19-2-6-22(28)7-3-19)20-4-8-23(29)9-5-20/h2-9,16-17H,10-15H2,1H3

描述信息

D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents
D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents
D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants
C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist
Ritanserin (R 55667) is a highly potent, relatively selective, orally active, long acting antagonist of 5-HT2 receptor, with an IC50 of 0.9 nM, less active on Histamine H1, Dopamine D2, Adrenergic α1, Adrenergic α2 receptors[1].

同义名列表

13 个代谢物同义名

6-(2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl)-7-methyl-5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one; 6-(2-(4-(Bis(4-fluorophenyl)methylene)-1-piperidinyl)ethyl)-7-methyl-5H-thiazolo(3,2-a)pyrimidin-5-one; 6-(2-(4-(Bis(p-fluorophenyl)methylene)-piperidino)ethyl)-7-methyl-5H-thiazolo-(3,2-a)pyrimidin-5-one; Ritanserin hydrochloride; Ritanserin tartrate; Ritanserinum; Ritanserine; Ritanserina; ritanserin; Tiserton; R 55,667; R-55667; R 55667



数据库引用编号

10 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。

亚细胞结构定位 关联基因列表


文献列表

  • Mitchell E Granade, Laryssa C Manigat, Michael C Lemke, Benjamin W Purow, Thurl E Harris. Identification of ritanserin analogs that display DGK isoform specificity. Biochemical pharmacology. 2022 03; 197(?):114908. doi: 10.1016/j.bcp.2022.114908. [PMID: 34999054]
  • Mark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, Susanne Bäck, Adam Yasgar, Emily S Wires, Carina Danchik, Xiaokang Yan, Hideaki Yano, Lei Shi, Kuo-Jen Wu, Amy Q Wang, Dingyin Tao, Gergely Zahoránszky-Kőhalmi, Xin Hu, Xin Xu, David Maloney, Alexey V Zakharov, Ganesha Rai, Fumihiko Urano, Mikko Airavaara, Oksana Gavrilova, Ajit Jadhav, Yun Wang, Anton Simeonov, Brandon K Harvey. A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. Cell reports. 2021 04; 35(4):109040. doi: 10.1016/j.celrep.2021.109040. [PMID: 33910017]
  • Andrii Kovalenko, Andres Sanin, Kosmas Kosmas, Long Zhang, Ji Wang, Elie W Akl, Krinio Giannikou, Clemens K Probst, Thomas R Hougard, Ryan W Rue, Vera P Krymskaya, John M Asara, Hilaire C Lam, David J Kwiatkowski, Elizabeth P Henske, Harilaos Filippakis. Therapeutic Targeting of DGKA-Mediated Macropinocytosis Leads to Phospholipid Reprogramming in Tuberous Sclerosis Complex. Cancer research. 2021 04; 81(8):2086-2100. doi: 10.1158/0008-5472.can-20-2218. [PMID: 33593821]
  • Tobie D Lee, Olivia W Lee, Kyle R Brimacombe, Lu Chen, Rajarshi Guha, Sabrina Lusvarghi, Bethilehem G Tebase, Carleen Klumpp-Thomas, Robert W Robey, Suresh V Ambudkar, Min Shen, Michael M Gottesman, Matthew D Hall. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Molecular pharmacology. 2019 11; 96(5):629-640. doi: 10.1124/mol.119.115964. [PMID: 31515284]
  • Sean T Campbell, Caroline E Franks, Adam L Borne, Myungsun Shin, Liuzhi Zhang, Ku-Lung Hsu. Chemoproteomic Discovery of a Ritanserin-Targeted Kinase Network Mediating Apoptotic Cell Death of Lung Tumor Cells. Molecular pharmacology. 2018 11; 94(5):1246-1255. doi: 10.1124/mol.118.113001. [PMID: 30158316]
  • Moustafa T Gabr, Mohammed S Abdel-Raziq. Pharmacophore-based tailoring of biphenyl amide derivatives as selective 5-hydroxytryptamine 2B receptor antagonists. MedChemComm. 2018 Jun; 9(6):1069-1075. doi: 10.1039/c8md00204e. [PMID: 30108996]
  • Bethany A O'Hara, Gretchen V Gee, Walter J Atwood, Sheila A Haley. Susceptibility of Primary Human Choroid Plexus Epithelial Cells and Meningeal Cells to Infection by JC Virus. Journal of virology. 2018 04; 92(8):. doi: 10.1128/jvi.00105-18. [PMID: 29437972]
  • Rebecca L McCloud, Caroline E Franks, Sean T Campbell, Benjamin W Purow, Thurl E Harris, Ku-Lung Hsu. Deconstructing Lipid Kinase Inhibitors by Chemical Proteomics. Biochemistry. 2018 01; 57(2):231-236. doi: 10.1021/acs.biochem.7b00962. [PMID: 29155586]
  • Caroline E Franks, Sean T Campbell, Benjamin W Purow, Thurl E Harris, Ku-Lung Hsu. The Ligand Binding Landscape of Diacylglycerol Kinases. Cell chemical biology. 2017 Jul; 24(7):870-880.e5. doi: 10.1016/j.chembiol.2017.06.007. [PMID: 28712745]
  • Giuseppe Mancuso, Gigliola Borgonovo, Leonardo Scaglioni, Angela Bassoli. Phytochemicals from Ruta graveolens Activate TAS2R Bitter Taste Receptors and TRP Channels Involved in Gustation and Nociception. Molecules (Basel, Switzerland). 2015 Oct; 20(10):18907-22. doi: 10.3390/molecules201018907. [PMID: 26501253]
  • Bhanu P S Kaurav, Manish M Wanjari, Amol Chandekar, Nagendra Singh Chauhan, Neeraj Upmanyu. Influence of Withania somnifera on obsessive compulsive disorder in mice. Asian Pacific journal of tropical medicine. 2012 May; 5(5):380-4. doi: 10.1016/s1995-7645(12)60063-7. [PMID: 22546655]
  • Noriko Yamada, Hiroaki Araki, Hiroyuki Yoshimura. Identification of antidepressant-like ingredients in ginseng root (Panax ginseng C.A. Meyer) using a menopausal depressive-like state in female mice: participation of 5-HT2A receptors. Psychopharmacology. 2011 Aug; 216(4):589-99. doi: 10.1007/s00213-011-2252-1. [PMID: 21424694]
  • Gbolagade Sunmaila Akintomide, Hugh Rickards. Narcolepsy: a review. Neuropsychiatric disease and treatment. 2011; 7(?):507-18. doi: 10.2147/ndt.s23624. [PMID: 21931493]
  • Michael T Bowen, Dean S Carson, Adena Spiro, Jonathon C Arnold, Iain S McGregor. Adolescent oxytocin exposure causes persistent reductions in anxiety and alcohol consumption and enhances sociability in rats. PloS one. 2011; 6(11):e27237. doi: 10.1371/journal.pone.0027237. [PMID: 22110618]
  • Maria Verena Cicala, Franco Mantero. Hypertension in Cushing's syndrome: from pathogenesis to treatment. Neuroendocrinology. 2010; 92 Suppl 1(?):44-9. doi: 10.1159/000314315. [PMID: 20829617]
  • Asunción Morán, Ana-Vega Ortiz de Urbina, María-Luisa Martín, Alicia Rodríguez-Barbero, Luis San Román. Characterization of the contractile 5-hydroxytryptamine receptor in the autoperfused kidney of L-NAME hypertensive rats. European journal of pharmacology. 2009 Oct; 620(1-3):90-6. doi: 10.1016/j.ejphar.2009.08.026. [PMID: 19699736]
  • G Froldi, G Zagotto, R Filippini, M Montopoli, P Dorigo, L Caparrotta. Activity of sap from Croton lechleri on rat vascular and gastric smooth muscles. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2009 Aug; 16(8):768-75. doi: 10.1016/j.phymed.2009.02.003. [PMID: 19406630]
  • Hitoshi Hashimoto, Ryota Hashimoto, Norihito Shintani, Kazuhiro Tanaka, Akiko Yamamoto, Michiyoshi Hatanaka, Xiaohong Guo, Yoshiko Morita, Mamoru Tanida, Katsuya Nagai, Masatoshi Takeda, Akemichi Baba. Depression-like behavior in the forced swimming test in PACAP-deficient mice: amelioration by the atypical antipsychotic risperidone. Journal of neurochemistry. 2009 Jul; 110(2):595-602. doi: 10.1111/j.1471-4159.2009.06168.x. [PMID: 19457081]
  • Meritxell Canals, Juan F Lopez-Gimenez, Graeme Milligan. Cell surface delivery and structural re-organization by pharmacological chaperones of an oligomerization-defective alpha(1b)-adrenoceptor mutant demonstrates membrane targeting of GPCR oligomers. The Biochemical journal. 2009 Jan; 417(1):161-72. doi: 10.1042/bj20081227. [PMID: 18764782]
  • Asunción Morán, Ana-Vega Ortiz de Urbina, Maria-Luisa Martín, Mónica García, Alicia Rodriguez-Barbero, Fernando Dorado, Luis San Román. Characterization of contractile 5-hydroxytryptamine receptor subtypes in the in situ autoperfused kidney in the anaesthetized rat. European journal of pharmacology. 2008 Sep; 592(1-3):133-7. doi: 10.1016/j.ejphar.2008.06.106. [PMID: 18644367]
  • Elke Ericson, Marinella Gebbia, Lawrence E Heisler, Jan Wildenhain, Mike Tyers, Guri Giaever, Corey Nislow. Off-target effects of psychoactive drugs revealed by genome-wide assays in yeast. PLoS genetics. 2008 Aug; 4(8):e1000151. doi: 10.1371/journal.pgen.1000151. [PMID: 18688276]
  • Rui Wang, Ying Xu, Hong-Li Wu, Ying-Bo Li, Yu-Hua Li, Jia-Bin Guo, Xue-Jun Li. The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors. European journal of pharmacology. 2008 Jan; 578(1):43-50. doi: 10.1016/j.ejphar.2007.08.045. [PMID: 17942093]
  • Yingjie Wang, Werner Beck, Reinhold Deppisch, Sally M Marshall, Nicholas A Hoenich, Michael G Thompson. Differential effects of dialysis and ultrafiltrate from individuals with CKD, with or without diabetes, on platelet phosphatidylserine externalization. American journal of physiology. Renal physiology. 2008 Jan; 294(1):F220-8. doi: 10.1152/ajprenal.00279.2007. [PMID: 17670899]
  • Ming-Chin Lu, Ming-Tsuen Hsieh, Chi-Rei Wu, Hao-Yuan Cheng, Chia-Chang Hsieh, Yao-Tung Lin, Wen-Huang Peng. Ameliorating effect of emodin, a constitute of Polygonatum multiflorum, on cycloheximide-induced impairment of memory consolidation in rats. Journal of ethnopharmacology. 2007 Jul; 112(3):552-6. doi: 10.1016/j.jep.2007.05.004. [PMID: 17572029]
  • Yingjie Wang, Werner Beck, Reinhold Deppisch, Sally M Marshall, Nicholas A Hoenich, Michael G Thompson. Advanced glycation end products elicit externalization of phosphatidylserine in a subpopulation of platelets via 5-HT2A/2C receptors. American journal of physiology. Cell physiology. 2007 Jul; 293(1):C328-36. doi: 10.1152/ajpcell.00560.2006. [PMID: 17625040]
  • E Elisabetsky, L Costa-Campos. The alkaloid alstonine: a review of its pharmacological properties. Evidence-based complementary and alternative medicine : eCAM. 2006 Mar; 3(1):39-48. doi: 10.1093/ecam/nek011. [PMID: 16550222]
  • David R Thomas, Christopher G Larminie, Helen R Lyons, Andrew Fosberry, Matthew J Hill, Philip D Hayes. Cloning and pharmacological characterisation of the guinea pig 5-ht5A receptor. European journal of pharmacology. 2004 Jun; 494(2-3):91-9. doi: 10.1016/j.ejphar.2004.04.027. [PMID: 15212962]
  • Jeffrey Sprouse, Linda Reynolds, Xingfang Li, John Braselton, Anne Schmidt. 8-OH-DPAT as a 5-HT7 agonist: phase shifts of the circadian biological clock through increases in cAMP production. Neuropharmacology. 2004 Jan; 46(1):52-62. doi: 10.1016/j.neuropharm.2003.08.007. [PMID: 14654097]
  • Julie Y Crider, Gary W Williams, Colene D Drace, Parvaneh Katoli, Michelle Senchyna, Najam A Sharif. Pharmacological characterization of a serotonin receptor (5-HT7) stimulating cAMP production in human corneal epithelial cells. Investigative ophthalmology & visual science. 2003 Nov; 44(11):4837-44. doi: 10.1167/iovs.02-1292. [PMID: 14578406]
  • Piet Borgdorff, Durk Fekkes, Geert Jan Tangelder. Hypotension caused by extracorporeal circulation: serotonin from pump-activated platelets triggers nitric oxide release. Circulation. 2002 Nov; 106(20):2588-93. doi: 10.1161/01.cir.0000036082.04708.83. [PMID: 12427656]
  • Lisa M Schrott, Mary Irene Baumgart, Xuewei Zhang, Sheldon B Sparber. Prenatal opiate withdrawal activates the chick embryo hypothalamic pituitary-adrenal axis and dilates vitelline blood vessels via serotonin(2) receptors. The Journal of pharmacology and experimental therapeutics. 2002 Oct; 303(1):257-64. doi: 10.1124/jpet.102.037044. [PMID: 12235259]
  • Nina K Popova, Tamara G Amstislavskaya. 5-HT2A and 5-HT2C serotonin receptors differentially modulate mouse sexual arousal and the hypothalamo-pituitary-testicular response to the presence of a female. Neuroendocrinology. 2002 Jul; 76(1):28-34. doi: 10.1159/000063681. [PMID: 12097814]
  • Walid Abi-Saab, John P Seibyl, D Cyril D'Souza, Laurence P Karper, Ralitza Gueorgueva, Anissa Abi-Dargham, Ma-Li Wong, Sachin Rajhans, Joseph P Erdos, George R Heninger, Dennis S Charney, John H Krystal. Ritanserin antagonism of m-chlorophenylpiperazine effects in neuroleptic-free schizophrenics patients: support for serotonin-2 receptor modulation of schizophrenia symptoms. Psychopharmacology. 2002 Jun; 162(1):55-62. doi: 10.1007/s00213-002-1057-7. [PMID: 12107618]
  • Yumiko Tozawa, Kouji Matsushima. Peripheral 5-HT(2A)-receptor-mediated formation of an inhibitor of atrial natriuretic peptide binding involves inflammation. European journal of pharmacology. 2002 Apr; 440(1):37-44. doi: 10.1016/s0014-2999(02)01310-9. [PMID: 11959086]
  • L Rauser, J E Savage, H Y Meltzer, B L Roth. Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine(2C) receptor. The Journal of pharmacology and experimental therapeutics. 2001 Oct; 299(1):83-9. doi: . [PMID: 11561066]
  • E B Larson, L M Schrott, L Bordone, S B Sparber. Embryonic cocaine exposure and corticosterone: serotonin(2) receptor mediation. Pharmacology, biochemistry, and behavior. 2001 May; 69(1-2):71-5. doi: 10.1016/s0091-3057(01)00502-0. [PMID: 11420070]
  • J W Cornish, I Maany, P J Fudala, R N Ehrman, S J Robbins, C P O'Brien. A randomized, double-blind, placebo-controlled study of ritanserin pharmacotherapy for cocaine dependence. Drug and alcohol dependence. 2001 Jan; 61(2):183-9. doi: 10.1016/s0376-8716(00)00140-x. [PMID: 11137283]
  • Y Sugimoto, J Yamada. Effects of the 5-HT2A receptor agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) on plasma glucose and glucagon levels of rats. Biological & pharmaceutical bulletin. 2000 Dec; 23(12):1521-3. doi: 10.1248/bpb.23.1521. [PMID: 11145190]
  • A Siddiqui, K Kotecha, A M Salicioni, V Kalia, J F Murray, C A Wilson. Serotonin inhibits luteinizing hormone release via 5-HT1A receptors in the zona incerta of ovariectomised, anaesthetised rats primed with steroids. Neuroendocrinology. 2000 Nov; 72(5):272-83. doi: 10.1159/000054596. [PMID: 11124584]
  • J Yamada, Y Sugimoto. The 5-HT(2C/2B) receptor agonist, m-chlorophenylpiperazine, increases plasma glucagon levels in rats. European journal of pharmacology. 2000 Oct; 406(1):153-7. doi: 10.1016/s0014-2999(00)00644-0. [PMID: 11011047]
  • N Sonino, G A Fava, F Fallo, A Franceschetto, P Belluardo, M Boscaro. Effect of the serotonin antagonists ritanserin and ketanserin in Cushing's disease. Pituitary. 2000 Oct; 3(2):55-9. doi: 10.1023/a:1009986822146. [PMID: 11141696]
  • S J Robbins, R N Ehrman, A R Childress, J W Cornish, C P O'Brien. Mood state and recent cocaine use are not associated with levels of cocaine cue reactivity. Drug and alcohol dependence. 2000 Apr; 59(1):33-42. doi: 10.1016/s0376-8716(99)00103-9. [PMID: 10706973]
  • L M Schrott, W A Sweeney, K E Bodensteiner, S B Sparber. Late embryonic ritanserin exposure fails to alter normal responses to immune system stimulation in young chicks. Pharmacology, biochemistry, and behavior. 1999 Sep; 64(1):81-8. doi: 10.1016/s0091-3057(99)00096-9. [PMID: 10495001]
  • D W Bonhaus, L A Flippin, R J Greenhouse, S Jaime, C Rocha, M Dawson, K Van Natta, L K Chang, T Pulido-Rios, A Webber, E Leung, R M Eglen, G R Martin. RS-127445: a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist. British journal of pharmacology. 1999 Jul; 127(5):1075-82. doi: 10.1038/sj.bjp.0702632. [PMID: 10455251]
  • C Reavill, A Kettle, V Holland, G Riley, T P Blackburn. Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist. British journal of pharmacology. 1999 Feb; 126(3):572-4. doi: 10.1038/sj.bjp.0702350. [PMID: 10188965]
  • M Verbeke, J Van de Voorde, L de Ridder, N Lameire. Beneficial effect of serotonin 5-HT2-receptor antagonism on renal blood flow autoregulation in cyclosporin-treated rats. Journal of the American Society of Nephrology : JASN. 1999 Jan; 10(1):28-34. doi: 10.1681/asn.v10128. [PMID: 9890306]
  • J Yamada, Y Sugimoto, T Yoshikawa. p-Chloroamphetamine, a serotonin-releasing drug, elicited in rats a hyperglycemia mediated by the 5-HT1A and 5-HT2B/2C receptors. European journal of pharmacology. 1998 Oct; 359(2-3):185-90. doi: 10.1016/s0014-2999(98)00639-6. [PMID: 9832390]
  • C Bregonzio, C E Navarro, A O Donoso. NMDA receptor antagonists block stress-induced prolactin release in female rats at estrus. European journal of pharmacology. 1998 Jun; 350(2-3):259-65. doi: 10.1016/s0014-2999(98)00251-9. [PMID: 9696416]
  • G Bollweg, Y X Wei, S B Sparber. Behavioral and neuroendocrine assessment of ritanserin exposure in the developing chicken: lack of toxicity at effective doses. Pharmacology, biochemistry, and behavior. 1998 May; 60(1):175-81. doi: 10.1016/s0091-3057(97)00577-7. [PMID: 9610940]
  • R Meeusen, J Roeykens, L Magnus, H Keizer, K De Meirleir. Endurance performance in humans: the effect of a dopamine precursor or a specific serotonin (5-HT2A/2C) antagonist. International journal of sports medicine. 1997 Nov; 18(8):571-7. doi: 10.1055/s-2007-972683. [PMID: 9443587]
  • F G Boess, F J Monsma, V Meyer, C Zwingelstein, A J Sleight. Interaction of tryptamine and ergoline compounds with threonine 196 in the ligand binding site of the 5-hydroxytryptamine6 receptor. Molecular pharmacology. 1997 Sep; 52(3):515-23. doi: 10.1124/mol.52.3.515. [PMID: 9284367]
  • T F Meert, W Melis, N Aerts, G Clincke. Antagonism of meta-chlorophenylpiperazine-induced inhibition of exploratory activity in an emergence procedure, the open field test, in rats. Behavioural pharmacology. 1997 Aug; 8(4):353-63. doi: 10.1097/00008877-199708000-00008. [PMID: 9832994]
  • J E Leysen, W Gommeren, L Heylen, W H Luyten, I Van de Weyer, P Vanhoenacker, G Haegeman, A Schotte, P Van Gompel, R Wouters, A S Lesage. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan. Molecular pharmacology. 1996 Dec; 50(6):1567-80. doi: . [PMID: 8967979]
  • C Gronfier, R Luthringer, M Follenius, N Schaltenbrand, J P Macher, A Muzet, G Brandenberger. A quantitative evaluation of the relationships between growth hormone secretion and delta wave electroencephalographic activity during normal sleep and after enrichment in delta waves. Sleep. 1996 Dec; 19(10):817-24. doi: 10.1093/sleep/19.10.817. [PMID: 9085491]
  • G Brandenberger, R Luthringer, G Muller, C Gronfier, N Schaltenbrand, J P Macher, A Muzet, M Follenius. 5-HT2 receptors are partially involved in the relationship between renin release and delta relative power. Journal of endocrinological investigation. 1996 Sep; 19(8):556-62. doi: 10.1007/bf03349016. [PMID: 8905480]
  • R Sandyk. Bidirectional effect of electromagnetic fields on ketanserin-induced yawning in patients with multiple sclerosis: the role of melatonin. The International journal of neuroscience. 1996 Mar; 85(1-2):93-9. doi: 10.3109/00207459608986354. [PMID: 8727685]
  • P J Pauwels, C Palmier, T Wurch, F C Colpaert. Pharmacology of cloned human 5-HT1D receptor-mediated functional responses in stably transfected rat C6-glial cell lines: further evidence differentiating human 5-HT1D and 5-HT1B receptors. Naunyn-Schmiedeberg's archives of pharmacology. 1996 Jan; 353(2):144-56. doi: 10.1007/bf00168751. [PMID: 8717154]
  • C Gronfier, R Luthringer, M Follenius, N Schaltenbrand, J P Macher, A Muzet, G Brandenberger. Temporal link between plasma thyrotropin levels and electroencephalographic activity in man. Neuroscience letters. 1995 Nov; 200(2):97-100. doi: 10.1016/0304-3940(95)12082-f. [PMID: 8614572]
  • F Estevez, S Parrillo, M Giusti, J M Monti. Single-dose ritanserin and alcohol in healthy volunteers: a placebo-controlled trial. Alcohol (Fayetteville, N.Y.). 1995 Nov; 12(6):541-5. doi: 10.1016/0741-8329(95)00041-0. [PMID: 8590616]
  • D Morelowska-Spierzak, D Pawlak, W Buczko. Influence of captopril on the serotonin-induced vasopressor effect in tail artery isolated from two-kidney, one-clip renal hypertensive rats. Polish journal of pharmacology. 1995 Sep; 47(5):417-22. doi: . [PMID: 8868133]
  • D Tepavcević, Z Giljević, I Aganović, M Korsić, S Halimi, E Suchanek, T Jelić, B Kozić, V Plavsić. Effects of ritanserin, a specific serotonin-S2 receptor antagonist, on the release of anterior pituitary hormones during insulin-induced hypoglycemia in normal humans. Journal of endocrinological investigation. 1995 Jun; 18(6):427-30. doi: 10.1007/bf03349740. [PMID: 7594236]
  • F Estévez, M Giusti, J Monti. Ritanserin pharmacokinetics in abstinent chronic alcoholics. Medicina. 1995; 55(1):39-44. doi: NULL. [PMID: 7565034]
  • C P Hsieh, K Sakai, G C Bruns, R C Dage. Effects of MDL 28,133A, a 5-HT2 receptor antagonist, on platelet aggregation and coronary thrombosis in dogs. Journal of cardiovascular pharmacology. 1994 Nov; 24(5):761-72. doi: 10.1097/00005344-199424050-00011. [PMID: 7532754]
  • W Löscher, C Gerdes, A Richter. Lack of prophylactic or therapeutic efficacy of 5-HT2A receptor antagonists in halothane-induced porcine malignant hyperthermia. Naunyn-Schmiedeberg's archives of pharmacology. 1994 Oct; 350(4):365-74. doi: 10.1007/bf00178953. [PMID: 7845474]
  • F A Wiesel, A L Nordström, L Farde, B Eriksson. An open clinical and biochemical study of ritanserin in acute patients with schizophrenia. Psychopharmacology. 1994 Feb; 114(1):31-8. doi: 10.1007/bf02245441. [PMID: 7846205]
  • A Albinsson, E Palazidou, J Stephenson, G Andersson. Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release. European journal of pharmacology. 1994 Jan; 251(2-3):157-61. doi: 10.1016/0014-2999(94)90396-4. [PMID: 8149973]
  • R C Dow, B C Williams, J Bennie, S Carroll, G Fink. A central 5-HT2 receptor mechanism plays a key role in the proestrous surge of luteinizing hormone in the rat. Psychoneuroendocrinology. 1994; 19(4):395-9. doi: 10.1016/0306-4530(94)90019-1. [PMID: 8047643]
  • C M Faull, J A Charlton, T J Butler, P H Baylis. The effect of acute pharmacological manipulation of central serotonin neurotransmission on osmoregulated secretion of arginine vasopressin in the rat. The Journal of endocrinology. 1993 Oct; 139(1):77-87. doi: 10.1677/joe.0.1390077. [PMID: 8254296]
  • J M Monti, P Alterwain, F Estévez, F Alvariño, M Giusti, S Olivera, P Labraga. The effects of ritanserin on mood and sleep in abstinent alcoholic patients. Sleep. 1993 Oct; 16(7):647-54. doi: 10.1093/sleep/16.7.647. [PMID: 8290859]
  • Y Shen, F J Monsma, M A Metcalf, P A Jose, M W Hamblin, D R Sibley. Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. The Journal of biological chemistry. 1993 Aug; 268(24):18200-4. doi: . [PMID: 8394362]
  • M Fernández, P Pizcueta, J C García-Pagán, F Feu, I Cirera, J Bosch, J Rodés. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation. Hepatology (Baltimore, Md.). 1993 Aug; 18(2):389-93. doi: 10.1002/hep.1840180224. [PMID: 8340068]
  • G Bagdy, K T Kalogeras. Stimulation of 5-HT1A and 5-HT2/5-HT1C receptors induce oxytocin release in the male rat. Brain research. 1993 May; 611(2):330-2. doi: 10.1016/0006-8993(93)90521-n. [PMID: 8334526]
  • D Trenk, K U Seiler, M Buschmann, S Szathmary, H P Benn, E Jähnchen. Effect of concomitantly administered cimetidine or ranitidine on the pharmacokinetics of the 5-HT2-receptor antagonist ritanserin. Journal of clinical pharmacology. 1993 Apr; 33(4):330-4. doi: 10.1002/j.1552-4604.1993.tb04665.x. [PMID: 8473547]
  • K Endlich, R Kühn, M Steinhausen. Visualization of serotonin effects on renal vessels of rats. Kidney international. 1993 Feb; 43(2):314-23. doi: 10.1038/ki.1993.49. [PMID: 8441228]
  • J Yamada, Y Sugimoto, I Kimura, Y Watanabe, N Takeuchi, K Horisaka. Peripherally administered serotonin induces hyperglucagonemia in mice. Life sciences. 1993; 52(23):1845-9. doi: 10.1016/0024-3205(93)90004-m. [PMID: 8502121]
  • M Pertsch, E Krause, R Hirschelmann. A comparison of serotonin (5-HT) blood levels and activity of 5-HT2 antagonists in adjuvant arthritic Lewis and Wistar rats. Agents and actions. 1993; 38 Spec No(?):C98-101. doi: 10.1007/bf01991150. [PMID: 8317334]
  • C S Aulakh, J L Hill, D L Murphy. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats. The Journal of pharmacology and experimental therapeutics. 1992 Nov; 263(2):588-95. doi: . [PMID: 1432690]
  • A D Levy, P A Rittenhouse, Q Li, J E Kerr, T M Cabrera, G Battaglia, L D Van de Kar. Cocaine-induced suppression of renin secretion is partially mediated by serotonergic mechanisms. Pharmacology, biochemistry, and behavior. 1992 Jul; 42(3):481-6. doi: 10.1016/0091-3057(92)90143-4. [PMID: 1409781]
  • H Oguchi, M Terashima, T Koiwai, S Kawa, S Furuta, M Kobayashi, T Homma. Effects of the S2-serotonergic receptor antagonist, ketanserin, on cerulein-induced pancreatitis in the rat. Life sciences. 1992; 50(10):733-7. doi: 10.1016/0024-3205(92)90476-6. [PMID: 1371180]
  • F Nevens, M P Pizcueta, M Fernández, J Bosch, J Rodés. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in portal hypertensive rats. Hepatology (Baltimore, Md.). 1991 Dec; 14(6):1174-8. doi: 10.1002/hep.1840140636. [PMID: 1959867]
  • P A Rittenhouse, E A Bakkum, L D Van de Kar. Evidence that the serotonin agonist, DOI, increases renin secretion and blood pressure through both central and peripheral 5-HT2 receptors. The Journal of pharmacology and experimental therapeutics. 1991 Oct; 259(1):58-65. doi: NULL. [PMID: 1920135]
  • J Zazgornik, J Kuska, F Kokot, S Koch, A Van Peer, M L Huang, J Heykants. Pharmacokinetics of ritanserin in patients undergoing hemodialysis. Journal of clinical pharmacology. 1991 Jul; 31(7):657-61. doi: 10.1002/j.1552-4604.1991.tb03752.x. [PMID: 1910052]
  • J A Saydoff, P A Rittenhouse, L D van de Kar, M S Brownfield. Enhanced serotonergic transmission stimulates oxytocin secretion in conscious male rats. The Journal of pharmacology and experimental therapeutics. 1991 Apr; 257(1):95-9. doi: NULL. [PMID: 1850481]
  • R J Barrett, K F Wright, A D Allen, D R Taylor. Cardiovascular and renal actions of AHR-16303B, an antagonist of 5-HT2 receptors and calcium channels, in hypertensive and normotensive rats. Journal of cardiovascular pharmacology. 1991 Jan; 17(1):134-44. doi: 10.1097/00005344-199101000-00019. [PMID: 1708047]
  • M A Lee, J F Nash, M Barnes, H Y Meltzer. Inhibitory effect of ritanserin on the 5-hydroxytryptophan-mediated cortisol, ACTH and prolactin secretion in humans. Psychopharmacology. 1991; 103(2):258-64. doi: 10.1007/bf02244213. [PMID: 1851310]
  • T Shoji, H Kiyomoto, T Tamaki, H Iwao, Y Abe. Renal vasodilatation induced by DOI, a 5-HT2 receptor agonist, in the canine kidney. European journal of pharmacology. 1990 Nov; 190(1-2):247-50. doi: 10.1016/0014-2999(90)94133-i. [PMID: 2127572]
  • F Chaouloff, D Laude, V Baudrie. Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5-HT on plasma glucose and insulin levels in the rat. European journal of pharmacology. 1990 Oct; 187(3):435-43. doi: 10.1016/0014-2999(90)90370-l. [PMID: 2127400]
  • S E Gartside, P J Cowen. Mediation of ACTH and prolactin responses to 5-HTP by 5-HT2 receptors. European journal of pharmacology. 1990 Apr; 179(1-2):103-9. doi: 10.1016/0014-2999(90)90407-w. [PMID: 2163847]
  • M Suzukawa, H Nakamura. Effects of ketanserin tartrate on 3-hydroxy, 3-methylglutaryl coenzyme A reductase activity in cultured human skin fibroblasts. Cardiovascular drugs and therapy. 1990 Jan; 4 Suppl 1(?):69-72. doi: 10.1007/bf00053430. [PMID: 1981023]
  • J A Den Boer, H G Westenberg. Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin. Psychopharmacology. 1990; 102(1):85-94. doi: 10.1007/bf02245749. [PMID: 1697419]
  • P Timmerman, R Woestenborghs, H Lenoir, J Heykants. Deuterated ritanserin analysis by gas chromatography/mass spectrometry: a sensitive technique to study human ritanserin pharmacokinetics. Biomedical & environmental mass spectrometry. 1989 Jul; 18(7):498-502. doi: 10.1002/bms.1200180709. [PMID: 2505878]
  • K Hatano, K Ishiwata, K Kawashima, J Hatazawa, M Itoh, T Ido. D2-dopamine receptor specific brain uptake of carbon-11-labeled YM-09151-2. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 1989 Apr; 30(4):515-22. doi: . [PMID: 2567779]
  • G Di Renzo, S Amoroso, M Taglialatela, L Canzoniero, V Basile, A Fatatis, L Annunziato. Pharmacological characterization of serotonin receptors involved in the control of prolactin secretion. European journal of pharmacology. 1989 Mar; 162(2):371-3. doi: 10.1016/0014-2999(89)90302-6. [PMID: 2524399]
  • M L Cohen, W L Bloomquist, H D Snoddy, R W Fuller. Lack of a difference between ketanserin and ritanserin in central vs. peripheral serotonin receptor antagonism. Life sciences. 1989; 45(13):1185-9. doi: 10.1016/0024-3205(89)90507-9. [PMID: 2507847]
  • T Hedner, B Persson. Experience with ketanserin and ritanserin in hypertensive patients. Journal of cardiovascular pharmacology. 1988; 11 Suppl 1(?):S44-8. doi: NULL. [PMID: 2459514]
  • M Larsson, A Forsman. Ritanserin assessments in plasma and CSF by means of HPLC technique with fluorescence detection. Methods and findings in experimental and clinical pharmacology. 1987 Jun; 9(6):349-51. doi: NULL. [PMID: 2888936]
  • T Hedner, A Pettersson, B Persson. Chronic 5-HT2-receptor blockade by ritanserin does not reduce blood pressure in patients with essential hypertension. Acta medica Scandinavica. 1987; 222(4):307-10. doi: 10.1111/j.0954-6820.1987.tb10676.x. [PMID: 2892349]
  • F Facchinetti, E Martignoni, G Nappi, S Marini, F Petraglia, G Sandrini, A R Genazzani. Ritanserin, a serotonin-S2 receptor antagonist, does not prevent 5-hydroxytryptophan-induced beta-EP, beta-LPH and cortisol secretion. Hormone research. 1987; 27(1):42-6. doi: 10.1159/000180776. [PMID: 2957299]
  • J A Barone, R H Bierman, J W Cornish, A Hsuan, N D Drake, J L Colaizzi. Safety evaluation of ritanserin--an investigational serotonin antagonist. Drug intelligence & clinical pharmacy. 1986 Oct; 20(10):770-5. doi: 10.1177/106002808602001006. [PMID: 3095082]